It is believed that the process of reperfusion may set
|
|
- Gerard Goodwin
- 6 years ago
- Views:
Transcription
1 A Controlled Trial of Substrate-Enhanced, Warm Reperfusion ( Hot Shot ) Versus Simple Reperfusion Rhian Edwards, FRCA, Tom Treasure, FRCS, Mojgen Hossein-Nia, PhD, Andrew Murday, FRCS, George H. Kantidakis, MD, and David W. Holt, FRCPath Cardiothoracic Unit, St. George s Hospital, and Analytical Unit, Department of Cardiological Sciences, St. George s Hospital Medical School, London, England Background. Modified reperfusion after aortic crossclamping is claimed to reduce myocardial injury, thus improving postoperative myocardial performance. Methods. We measured perioperative release of creatine kinase-mb and troponin-t in 40 patients undergoing valve replacement (combined with coronary grafts in 12 cases) to determine whether infusion of a modified reperfusate before cross-clamp removal reduced myocardial injury. Patients were randomly allocated to one of two groups with minimization for age, surgeon, operation, and ventricular function. The control group received unmodified reperfusion, while the study group received a normothermic reperfusate, enhanced with glutamate and aspartate, for 5 minutes before removal of the cross-clamp. Serial determinations of troponin-t, creatine kinase-mb isoforms, and total creatine kinase- MB activity were made up to 5 days postoperatively. Requirements for inotropic support and evidence of myocardial infarction were documented. Results. Creatine kinase-mb activity, creatine kinase- MB isoforms, and troponin-t were not significantly different between the two groups. There were no differences in the incidence of postoperative myocardial infarction or in inotrope requirement. Conclusions. Our study did not demonstrate any advantage in using modified reperfusion in this group of patients. (Ann Thorac Surg 2000;69:551 5) 2000 by The Society of Thoracic Surgeons It is believed that the process of reperfusion may set in motion a train of events that result in myocardial dysfunction, arrhythmias, microvascular damage, and possibly acceleration of cell death [1]. The Journal of Thoracic and Cardiovascular Surgery has devoted two supplements entirely to the matters of optimal reperfusion [2, 3]. We shared the interest of others in the concept of reperfusion of the myocardium with blood, enhanced with substrates of an ideal composition to For editorial comment see page 334 replenish essential metabolites, in warm oxygenated blood, while the heart remains nonworking, arrested in diastole. This approach is known as a hot shot. The amino acids aspartate and glutamate enter the mitochondria on reperfusion to fuel the tricarboxylic acid cycle and hasten replenishment of high-energy phosphates [4]. The theoretical basis is compelling, but the evidence was largely based on experiments in dogs [2, 5, 6] and pigs [3, 4], and although there were clinical trials showing difference [7], much of the clinical discussion relies on remembered experience and historical controls. Nevertheless, Accepted for publication Sep 8, Address reprint requests to Dr Treasure, Cardiothoracic Unit, St. George s Hospital, Blackshaw Rd, Tooting, London SW17 0QT England; treasure@talfourd.u-net.com. the arguments for such a strategy have had such an appeal that the hot shot has been adopted as a routine clinical practice by many surgeons. Enzyme release has been used to detect myocardial damage during cardiac surgery. However, until recently, the measurement of total creatine kinase (CK-MB) was relatively insensitive, and the release of enzyme from other sources limited its value in comparing techniques of myocardial preservation. Measurements of CK-MB isoforms (MB2, the tissue isoform; and MB1, the plasma modified isoform) have been used as sensitive markers of ischemic myocardial damage as well as for early diagnosis of acute myocardial infarction [8 10], which allow detection of changes at activities within the normal range of CK-MB and are therefore extremely sensitive indices of myocardial damage. The measurement of troponin-t concentration has also been shown to be a useful marker of myocardial cell injury in a number of clinical settings, including the diagnosis of ischemic myocardial damage [11, 12]. We set out to study this reperfusion strategy in our own practice. Our coronary operations at that time were performed warm (nadir temperature 32 C) using only brief periods (5 to 10 minutes) of ischemia when required to perform the distal anastomosis [13, 14]. For valve surgery, we used cold blood cardioplegia, and it is in that group that we have investigated the benefits of modifying reperfusion rather than simply removing the cross by The Society of Thoracic Surgeons /00/$20.00 Published by Elsevier Science Inc PII S (99)
2 552 EDWARDS ET AL Ann Thorac Surg HOT SHOT VS SIMPLE REPERFUSION 2000;69:551 5 clamp. We have endeavored to recruit as many of the more complex cases, double valve operations, and those having combined valve and coronary surgery to look for a difference in more vulnerable cases with longer ischemic times. Material and Methods The study was approved by the district ethical committee and written informed consent was obtained from all patients. Forty patients undergoing aortic or mitral valve replacement or both, with or without coronary revascularization, between January and August 1993, were allocated to one of two groups by minimization. Minimization is a process of double-blind computer-based allocation that ensures that likely confounding variables are equally distributed between the two groups [15, 16]. These included urgent cases but not unstable angina or catheter laboratory emergencies or catastrophes. Patients were randomized for age (under or over 65 years), operating surgeon (T.T. or A.M.), nature of operation (aortic valve replacement, mitral valve replacement, or double valve replacement coronary artery bypass grafts), and left ventricular function (normal, impaired, or poor). Left ventricular function was not rigorously defined but is used in the process of minimization to avoid important discrepancies between groups at allocation. The anesthetic technique was standardized for all patients. After systemic heparinization (3 mg/kg) and cannulation of the heart, cardiopulmonary bypass was instituted with a D703 hollow-fiber oxygenator and a roller pump (D703; Shiley Dideco, Modena, Italy). Pump prime consisted of 2 L of Hartmann s solution. Blood cardioplegic solution in both groups contained 1 L of blood and 20 ml of cardioplegic solution (St. Thomas No. 1): magnesium chloride g, potassium chloride g, procaine mg, and disodium edetate 0.01%. This was infused antegradely, initially into the aortic root, supplemented by direct coronary infusion in the aortic valve cases and into vein grafts where appropriate, at a temperature of 4 C via a Gish Medical Cardioplegia System (Irvine, CA). Apical vents were used routinely by one surgeon (A.M.) but not the other (T.T.). Cardioplegia was repeated at 30-minute intervals or as required to ensure cardiac quiescence. The nasopharyngeal temperature of the patient was lowered to 28 C, and systemic blood flow was maintained at 2.4 L/m 2 /min. The procedure outlined above was identical for both groups until removal of the aortic cross-clamp. In the control group, designated A, the aortic cross-clamp was simply removed and reperfusion of the coronary arteries was unmodified, with a perfusion pressure not greater than 75 mm Hg. In the study group, designated B, a modified reperfusing solution made exactly as specified by Buckberg [17] was given. The buffered solution of electrolytes and substrates was provided by Edward Holt (Senior Pharmacist, Huddersfield Royal Infirmary), who has prepared the induction, maintenance, and reperfusion solutions according to Buckberg s [17] precise specifications for a group of surgeons who use these techniques consistently. One liter of the modified oxygenated blood was infused into the coronary arteries at a temperature of 37 C over 5 minutes at a pressure not greater than 75 mm Hg. We measured the ph, calcium, potassium, glucose, and osmolarity of the hot shot reperfusate as delivered (K 20 mmol/l, Ca mmol/l, ph 7.7, osmolarity mosm, aspartate 20.5 g/l, glutamate 22.4 g/l, glucose g/l). The aortic clamp was then removed and cardiopulmonary bypass discontinued when the myocardium was able to support the circulation. Throughout the reperfusion stages, by whichever technique or surgeon, left ventricular distension was actively avoided. Resuscitation drugs and support were administered as clinically indicated, and any requirement for inotropic or mechanical support was noted. Hemodynamic measurements made in both groups did not show any difference between them. A 5-day electrocardiogram (ECG) was analyzed for evidence of postoperative myocardial infarction by one of the workers (R.E.) who was blinded to the patient group. Arterial or peripheral venous (ie, mixed blood) samples for CK-MB activity and isoforms and troponin-t analysis were collected: (a) before induction of anesthesia; (b) after induction; (c) immediately after removal of the aortic cross-clamp; (d) at 30, 60, 90, and 120 minutes; (e) at 4, 6, 12, 24, 48, and 72 hours; (f) after 5 days. Blood samples for CK-MB activity and isoforms were collected into tubes containing disodium-ethyl-diamine tetraacetic acid (EDTA) and were spotted at a final concentration of 15 mmol/l. This concentration of EDTA inhibits carboxypeptidase-n-mediated isoform conversion after sample collection [18]. The blood samples were then centrifuged for 10 minutes at 2,000 rpm, and the plasma was removed for storage at 20 C until enzyme analysis. Blood samples for troponin-t concentration were collected in untreated tubes and centrifuged for 10 minutes at 2,000 rpm, and serum was removed for storage at 20 C until analysis. Analytical Methods Total CK-MB activity was measured immunochemically using Roche s Isomune kit (Roche Diagnostic Systems, Nutley, NJ) [19]. The MB2 and MB1 isoforms were separated by high-resolution agarose gel electrophoresis and the percentages quantified by densitometric scanning (REP; Helena Laboratories, UK Ltd., Tyne and Wear, UK) [9, 10]. The MB2/MB1 ratio was calculated by dividing the percentage of MB2 in the fractions, derived from densitometry, by that of MB1. Total CK-MB2 activity was calculated by multiplying the percentage of MB2 in the fractions by total CK-MB activity as measured by Roche s Isomune kit. The troponin-t concentration was measured using Enzymun-Test System (Boehringer Mannheim, Lewes, UK) on an ES-300 automated analyzer. Time-activity curves for each assay were constructed for each patient, peak levels were noted, and the area under the curve (AUC) was calculated as a means of expressing total substance release. The analysis of the difference in the peak enzyme release and area AUC between the two groups was performed using a Mann-
3 Ann Thorac Surg EDWARDS ET AL 2000;69:551 5 HOT SHOT VS SIMPLE REPERFUSION 553 Table 1. Preoperative Demographic Data in the Two Groups Control Group A : No Hot Shot Group B : Hot Shot (Modified Reperfusion) Age, median years (range) 64.5 (25 83) 61 (40 81) LV function Normal Impaired 8 6 Surgeon T.T A.M Operation Single valve Double valve 4 5 Valve CABG 3 3 Cross-clamp time Median IQR Range A.M. A. Murday; CABG coronary artery bypass grafting; IQR interquartile range; LV left ventricular; T.T. T. Treasure. Whitney U test. The significance level for difference for all tests was p less than Definition of Clinical End Points Death was defined as failure to leave hospital alive, for whatever reason. Usually, once the patient has been at 37 C for 20 minutes per hour of bypass time, we recommence intermittent positive pressure ventilation (IPPV), occlude the venous line, and discontinue perfusion within a minute or so. Failure to achieve this at the first attempt was defined as delay in coming off bypass. This was not a blinded end point. Inotropes were given according to clinical judgment. Ventricular arrhythmias were noted by the research fellow (R.E.), as observed from the monitor in theater. Table 2. Adverse Events in the Two Groups Control Group A : No Hot Shot Group B : Hot Shot (Modified Reperfusion) p Fig 1. The data for the area under the total MB release curve for each of the 40 patients. The characteristic log-normal distribution can be seen. (A) Control group; (B) modified reperfusion group with a hot shot. The vertical axis uses a log scale. Results Forty patients were studied as planned, 20 in each group. There were no preoperative differences between the groups with regard to the factors selected for minimization, that is age, left ventricular function, operating surgeon, or in the mix of operations performed (Table 1). There were no intraoperative differences between the groups with regard to aortic cross-clamp (median 47 minutes, range 30 to 88 minutes), cardiopulmonary bypass time (median 78 minutes, range 49 to 180 minutes), and hemodynamic measurements. The possible adverse outcomes are given in Table 2, which gives the incidence of death, use of intraaortic balloon pump (IABP), difficulty in weaning from bypass, need for inotropic support, stay in intensive care of more than 24 hours, or use of renal support. As they stand, apart from delay in coming off pump, these results are well within the limits of the fourfold table test [20]; however, a study of 40 Deaths 2/20 1/20 1 IABP 1/20 2/20 1 Delay in coming 2/20 15/ off-pump Inotropes 3/20 6/ h ITU 6/20 4/ Renal support 0/20 1/20 1 Apart from delay in coming off pump all these results are well within the limits of the fourfold table, so the two groups do not differ; however, a study of 40 patients has insufficient power to exclude differences in dichotomous events of relatively low frequency. To compare differences in proportions between groups, 2 and Fisher s exact test were used as appropriate. IABP intraaortic balloon pump; ITU intensive therapy unit. Fig 2. AUC for MB2 isoform. (A) Control group; (B) modified reperfusion group with a hot shot.
4 554 EDWARDS ET AL Ann Thorac Surg HOT SHOT VS SIMPLE REPERFUSION 2000;69:551 5 Fig 3. AUC for troponin T release. (A) Control group; (B) modified patients has insufficient power to exclude any differences in dichotomous events unless there is a very large discrepancy in outcome. In Figure 1, the data are displayed for the area under the total MB release curve for each of the 40 patients. The characteristic log-normal distribution can be seen. We use the box and whisker plots [21] in subsequent figures to summarize the AUC data for MB2 isoform and troponin-t (Figs 2, 3) and for peak MB, MB2, MB2/MB1 ratio, and troponin-t (Figs 4 7). There was no significant difference between the groups with regard to total CK- MB, the MB2 isoform, or troponin-t release, whether expressed as peak or AUC. Comment This is a pragmatic study [22] in which we have included a heterogeneous group of patients to see if there is a systematic benefit attributable to the hot shot. We have failed to show any difference in the postoperative release Fig 5. Peak MB2 displayed as box and whisker plots (median, interquartile range, and extreme range. (A) Control group; (B) modified of the MB2 isoform of CK, total CK-MB activity, or tropinin-t between modified ( hot shot ) and unmodified reperfusion. There is no hint of a trend in favor of the hot shot as used in this study. Furthermore, the distribution of the data points indicate that however large the trial, it is unlikely that any difference would emerge. We have chosen to do a small, detailed study of biochemical markers of myocardial damage. These are, of course, surrogate end points, but to reject the data we present, we would have to postulate that the beneficial effects of the hot shot are independent of the well-established indices of myocyte injury, which we have measured. Clinical trials of such a strategy are beset with difficulties. In the most vulnerable cases, who may well be the ones who would benefit most, it is not easy to randomize to a trial and it is then difficult to adhere to a protocol. If clinical events such as death are used, the trial has to be of considerable size to achieve significance and to avoid a beta error. For example, to show a statistically significant reduction from 5% mortality to 3% mortality would Fig 4. Peak MB, displayed as box and whisker plots (median, interquartile range, and extreme range). (A) Control group; (B) modified Fig 6. Peak MB2/MB1 ratio displayed as box and whisker plots (median, interquartile range, and extreme range). (A) Control group; (B) modified
5 Ann Thorac Surg EDWARDS ET AL 2000;69:551 5 HOT SHOT VS SIMPLE REPERFUSION 555 require over 4,000 cases. The more elective and safe the cases (and therefore the easier to recruit into trials), the lower the incidence of discrete events and therefore the larger the trial must be. The same argument applies if we take myocardial infarction as an outcome, but there is an additional problem. Anatomically discrete myocardial infarction, as judged by new Q waves, may be due to disease and technical failure, and then will not be preventable by this strategy. Global left ventricular injury, which is more likely to be ameliorated by a global strategy, is more difficult to define. Soft end points such as use of a balloon pump or inotropes, however the criteria are set, and length of stay in intensive care, are in the hands of the observers, and bias cannot be excluded. It could be argued that to show benefit, one needs to adopt the whole package with warm induction, perhaps use of warm perfusion, retrograde and antegrade perfusion, and then the replenishing solution. Indeed, each element might have to be evaluated in a series of extremely rigorous clinical studies, just as they have been systematically studied in an elaborate series of laboratory studies [2, 3]. It could be that our patients are not at sufficiently high risk to show a benefit from modification of reperfusion. It is true that in spite of our intention to study higher risk cases, more than half of the cases had good left ventricular function and more than half had a single valve operation. Furthermore, the median bypass was not long, at 78 minutes for the whole series, and ischemic times ranged from 30 to 88 minutes (median 47 minutes). In practice, we found that the additional manipulations added complexity to the operation, and in particular, the flaccid nature of the heart for several minutes after modified reperfusion necessitated special attention to the risk of increasing wall tension. Finally, the reperfusion solution adds a definite cost, equivalent to several hundred dollars, to each case. We cannot agree with Teoh and associates [7], who concluded: Because no adverse effects of warm blood cardioplegia were encountered, we would recommend a hot shot whenever cold blood Fig 7. Peak troponin T displayed as box and whisker plots (median, interquartile range, and extreme range). (A) Control group; (B) modified cardioplegia is employed for myocardial protection. We would need to establish benefit in clinical practice to adopt this technique as a routine, which this trial has failed to do. This study was supported by a grant from the British Heart Foundation (PG92077). References 1. Miura T. Does reperfusion induce myocardial necrosis? Circulation 1990;82: Buckberg GD. Studies of controlled reperfusion after ischaemia. I. When is cardiac muscle damaged irreversibly? J Thorac Cardiovasc Surg 1986;92 (Suppl 3 Pt 2): Buckberg GD. Studies of hypoxemic/reoxygenation injury. I. Linkage between cardiac function and oxidant damage. J Thorac Cardiovasc Surg 1995;110 (Suppl 4 Pt 2): Engelman RM, Rousou JA, Flack JE, Iyengar J, Kimura Y, Das DK. Reduction of infarct size by systemic aminoacid supplementation during reperfusion. J Thorac Cardiovasc Surg 1991;101: Follette DM, Fey K, Buckberg GD, et al. Reducing postischemic damage by temporary modification of reperfusate calcium, potassium, ph, and osmolarity. J Thorac Cardiovasc Surg 1981;82: Lazar HL, Buckberg GD, Manganaro AJ, et al. Reversal of ischemic damage with secondary blood cardioplegia. J Thorac Cardiovasc Surg 1979;78: Teoh KH, Christakis GT, Weisel RD, et al. Accelerated myocardial metabolic recovery with terminal warm blood cardioplegia. J Thorac Cardiovasc Surg 1986;91: Hossein-Nia M, Kallis P, Brown PA et al. Creatine kinase MB isoforms: sensitive markers of ischemic myocardial damage. Clin Chem 1994;40: Puleo PR, Guadagno PA, Roberts R, Perryman MB. Sensitive, rapid assay of subforms of creatine-kinase MB. Clin Chem 1989;35: Puleo PR, Guadagno PA, Roberts R, et al. Early diagnosis of acute myocardial infarction based on assay for subforms of creatine-kinase MB. Circulation 1990;82: Katus HA, Remppis A, Neumann FJ, et al. Diagnostic efficiency of tropinin-t measurements in acute myocardial infarction. Circulation 1991;83: Gerhardt W, Ljungdahl L, Herbert AK. Troponin-T and CK MB (mass) in early diagnosis of ischemic myocardial injury. The Helsingborg Study, Clin Biochem 1993;26: Anderson JR, Hossein-Nia M, Kallis P, et al. Comparison of two strategies of myocardial management during coronary artery operations. Ann Thorac Surg 1994;58: Liu Z, Valencia O, Treasure T, Murday AJ. Cold blood cardioplegia or intermittent cross-clamping in coronary artery bypass grafting? Ann Thorac Surg 1998;66: Treasure T, MacRae K. Minimization: the platinum standard for trials? Br Med J 1998;317: Pocock SJ. Clinical trials a practical approach. Chichester: Wiley, 1989: Buckberg GD. Antegrade/retrograde blood cardioplegia to ensure cardioplegic distribution: operative techniques and objectives. J Card Surg 1989;4: Davies J, Reynolds T, Penney MD. Creatine kinase isoforms: investigation of inhibitors of in vitro degradation and establishment of a reference range. Ann Clin Biochem 1992;29: Wicks RW, Usategui-Gomez M, Miller M, Warshaw M. Immunochemical determination of CKMB isoenzyme in human serum. II. An enzymic approach. Clin Chem 1982;28: Diem K, Lentner C. Documenta Geigy. Macclesfield: Geigy Pharmaceuticals, Wilson APR. Data presentation. Lancet 1993;341: Roland M, Torgerson DJ. What are pragmatic trials? Br Med J 1998;316:285.
IN ELECTIVE CORONARY ARTERY BYPASS GRAFTING, PREOPERATIVE TROPONIN T LEVEL PREDICTS THE RISK OF MYOCARDIAL INFARCTION
IN ELECTIVE CORONARY ARTERY BYPASS GRAFTING, PREOPERATIVE TROPONIN T LEVEL PREDICTS THE RISK OF MYOCARDIAL INFARCTION Michel Carrier, MD L. Conrad Pelletier, MD Raymond Martineau, MD Michel Pellerin, MD
More informationSteph ani eph ani Mi M ck i MD Cleveland Clinic
Stephanie Mick MD Stephanie Mick MD Cleveland Clinic Upper hemisternotomy AVR Ascending Aorta MVr Thoracotomy Based Anterior AVR Lateral Thoracotomy Mitral/Tricuspid surgery Robotically assisted surgery
More informationEmergency surgery in acute coronary syndrome
Emergency surgery in acute coronary syndrome Teerawoot Jantarawan Division of Cardiothoracic Surgery, Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
More informationSolution for cardiac perfusion in viaflex plastic container
CARDIOPLEGIA SOLUTION A Solution for cardiac perfusion in viaflex plastic container DESCRIPTION Cardioplegia Solution A is a sterile, non-pyrogenic solution in a Viaflex bag. It is used to induce cardiac
More informationWarm blood cardioplegia versus cold crystalloid cardioplegia for myocardial protection during coronary artery bypass grafting surgery
Nardi et al. Cell Death Discovery DOI 10.1038/s41420-018-0031-z Cell Death Discovery ARTICLE Warm blood cardioplegia versus cold crystalloid cardioplegia for myocardial protection during coronary artery
More informationConventional CABG Or On Pump Beating Heart: A Difference In Myocardial Injury?
Conventional CABG Or On Pump Beating Heart: A Difference In Myocardial Injury? Kornelis J. Koopmans Medical Center Leeuwarden Leeuwarden, The Netherlands I have no disclosures Disclosures Different techniques
More informationCritical coronary stenoses may limit the delivery of OPTIMAL FLOW RATES FOR INTEGRATED CARDIOPLEGIA
OPTIMAL FLOW RATES FOR INTEGRATED CARDIOPLEGIA Vivek Rao, MD Gideon Cohen, MD Richard D. Weisel, MD Noritsugu Shiono, MD, PhD Yoshiki Nonami, MD, PhD Susan M. Carson, AHT Joan Ivanov, RN, MSc Michael A.
More informationCardiac anaesthesia. Simon May
Cardiac anaesthesia Simon May Contents Cardiac: Principles of peri-operative management for cardiac surgery Cardiopulmonary bypass, cardioplegia and off pump cardiac surgery Cardiac disease and its implications
More informationIntraoperative Myocardial Protection: Current Trends and Future Perspectives
Intraoperative Myocardial Protection: Current Trends and Future Perspectives Gideon Cohen, MD, Michael A. Borger, MD, Richard D. Weisel, MD, and Vivek Rao, MD, PhD Division of Cardiovascular Surgery, The
More informationUseful? Definition of High-risk? Pre-OP/Intra-OP/Post-OP? Complication vs Benefit? Mortality? Morbidity?
Preoperative intraaortic balloon counterpulsation in high-risk CABG Stefan Klotz, M.D. Preoperative IABP in high-risk CABG Questions?? Useful? Definition of High-risk? Pre-OP/Intra-OP/Post-OP? Complication
More informationUnderstanding the Cardiopulmonary Bypass Machine and Its Tubing
Understanding the Cardiopulmonary Bypass Machine and Its Tubing Robert S. Leckie, MD Division of Cardiac Anesthesia, Beth Israel Deaconess Medical Center ABL 1/09 Reservoir Bucket This is a cartoon of
More informationCardiothoracic Fellow Expectations Division of Cardiac Anesthesia, Beth Israel Deaconess Medical Center
The fellowship in Cardiothoracic Anesthesia at the Beth Israel Deaconess Medical Center is intended to provide the foundation for a career as either an academic cardiothoracic anesthesiologist or clinical
More informationAnalysis of Mortality Within the First Six Months After Coronary Reoperation
Analysis of Mortality Within the First Six Months After Coronary Reoperation Frans M. van Eck, MD, Luc Noyez, MD, PhD, Freek W. A. Verheugt, MD, PhD, and Rene M. H. J. Brouwer, MD, PhD Departments of Thoracic
More informationMyocardial enzyme release after standard coronary artery bypass grafting
Cardiopulmonary Support and Physiology Schachner et al Myocardial enzyme release in totally endoscopic coronary artery bypass grafting on the arrested heart Thomas Schachner, MD, a Nikolaos Bonaros, MD,
More informationLeft ventricular (LV) hypertrophy increases end-diastolic
Retrograde Hot-Shot Cardioplegia in Patients With Left Ventricular Hypertrophy Undergoing Aortic Valve Replacement Raimondo Ascione, MD, Saadeh M. Suleiman, PhD, and Gianni D. Angelini, FRCS Bristol Heart
More informationAcute heart failure: ECMO Cardiology & Vascular Medicine 2012
Acute heart failure: ECMO Cardiology & Vascular Medicine 2012 Lucia Jewbali cardiologist-intensivist 14 beds/8 ICU beds Acute coronary syndromes Heart failure/ Cardiogenic shock Post cardiotomy Heart
More informationLactate Release During Reperfusion Predicts Low Cardiac Output Syndrome After Coronary Bypass Surgery
Lactate Release During Reperfusion Predicts Low Cardiac Output Syndrome After Coronary Bypass Surgery Vivek Rao, MD, PhD, Joan Ivanov, RN, MSc, Richard D. Weisel, MD, Gideon Cohen, MD, Michael A. Borger,
More informationSetting The setting was a hospital. The economic study was carried out in Australia.
Coronary artery bypass grafting (CABG) after initially successful percutaneous transluminal coronary angioplasty (PTCA): a review of 17 years experience Barakate M S, Hemli J M, Hughes C F, Bannon P G,
More informationIschemic Ventricular Septal Rupture
Ischemic Ventricular Septal Rupture Optimal Management Strategies Juan P. Umaña, M.D. Chief Medical Officer FCI Institute of Cardiology Disclosures Abbott Mitraclip Royalties Johnson & Johnson Proctor
More informationTransmyocardial Laser Revascularization: Epicardial ECG Detection Provides Efficient R-Wave Triggering during Mobilization of the Heart
Journal of Clinical Laser Medicine & Surgery Volume 21, Number 3, 2003 Mary Ann Liebert, Inc. Pp. 145 150 Transmyocardial Laser Revascularization: Epicardial ECG Detection Provides Efficient R-Wave Triggering
More informationGlobal Myocardial Protection
Global Myocardial Protection Edwards offers a wide range of antegrade and retrograde cardioplegia products designed to promote global myocardial protection. Complete Antegrade/Retrograde Solutions Edwards
More informationRapid Recovery After Coronary Artery Bypass Grafting: Is the Elderly Patient Eligible?
Rapid Recovery After Coronary Artery Bypass Grafting: Is the Elderly Patient Eligible? Richard A. Ott, MD, Dan E. Gutfinger, MD, PhD, Mark P. Miller, MD, Hossein Alimadadian, MD, and Teresa M. Tanner Division
More informationThe Journal of Thoracic and Cardiovascular Surgery
Accepted Manuscript Nitric Oxide: Might make it Better? J. Hunter Mehaffey, MD, MSc, Robert B. Hawkins, MD, MSc PII: S0022-5223(18)32342-0 DOI: 10.1016/j.jtcvs.2018.08.070 Reference: YMTC 13398 To appear
More informationDifficult Scenarios for Myocardial Protection SAHA Gil Bolotin M.D., Ph.D. Rambam Medical Center, Haifa, Israel
Difficult Scenarios for Myocardial Protection SAHA 2017 Gil Bolotin M.D., Ph.D. Rambam Medical Center, Haifa, Israel Difficult Scenarios for Myocardial Protection Stone Heart Nightmare Nightmare of the
More informationT techniques during cardiac operations has been to
Warm Heart Surgery and Results of Operation Recent Myocardial Infarction Samuel V. Lichtenstein, MD, PhD, James G. Abel, MD, and Tomas A. Salerno, MD Division of Cardiovascular Surgery, St. Michael's Hospital
More informationShould We Give Combined Antegrade-Retrograde Cardioplegia Rather Than Antegrade Alone in Patients with Left Main Coronary Disease?
1 Should We Give Combined Antegrade-Retrograde Cardioplegia Rather Than Antegrade Alone in Patients with Left Main Coronary Disease? 1 Nasr Hegazy, Khaled Fawzy, 2 Mostafa El-Hamamsy, 3 Abdelsalam Elhenawy
More informationINTERMEDIATE LUKEWARM (20 C) ANTEGRADE INTERMITTENT BLOOD CARDIOPLEGIA COMPARED WITH COLD AND WARM BLOOD CARDIOPLEGIA
INTERMEDIATE LUKEWARM (20 C) ANTEGRADE INTERMITTENT BLOOD CARDIOPLEGIA COMPARED WITH COLD AND WARM BLOOD CARDIOPLEGIA Sidney Chocron, MD, PhD a Djamel Kaili, MD a Yusheng Yan, MD a Gérard Toubin, MD b
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Ablation, radiofrequency, anesthetic considerations for, 479 489 Acute aortic syndrome, thoracic endovascular repair of, 457 462 aortic
More informationErik J. Fransen, MSc, PhD; Jart H. C. Diris, MSc; Jos G. Maessen, MD, PhD; Wim Th. Hermens, PhD; Marja P. van Dieijen-Visser, MD, PhD
Evaluation of New Cardiac Markers for Ruling Out Myocardial Infarction After Coronary Artery Bypass Grafting* Erik J. Fransen, MSc, PhD; Jart H. C. Diris, MSc; Jos G. Maessen, MD, PhD; Wim Th. Hermens,
More informationOPCAB IS NOT BETTER THAN CONVENTIONAL CABG
OPCAB IS NOT BETTER THAN CONVENTIONAL CABG Harold L. Lazar, M.D. Harold L. Lazar, M.D. Professor of Cardiothoracic Surgery Boston Medical Center and the Boston University School of Medicine Boston, MA
More informationDifferent results are reported for surgical myocardial
Surgical Revascularization for Acute Coronary Insufficiency: Analysis of Risk Factors for Hospital Mortality Biagio Tomasco, MD, Antonino Cappiello, MD, Rosario Fiorilli, MD, Archimede Leccese, MD, Raniero
More informationShould We Give Combined Antegrade-retrograde Cardioplegia Rather than Antegrade Alone in Patients with Left Main Coronary Disease?
Australian Journal of Basic and Applied Sciences, 3(1): 49-54, 2009 ISSN 1991-8178 Should We Give Combined Antegrade-retrograde Cardioplegia Rather than Antegrade Alone in Patients with Left Main Coronary
More informationThe beneficial effects of systemically administered
Magnesium-Supplemented Warm Blood Cardioplegia in Patients Undergoing Coronary Artery Revascularization Mark Yeatman, FRCS, Massimo Caputo, MD, Pradeep Narayan, FRCS, Attilio A. Lotto, MD, Raimondo Ascione,
More informationStrategies for myocardial protection vary among
Original Article EFFECT OF ROUTE OF CARDIOPLEGIA DELIVERY ON MYOCARDIAL PROTECTION Ammar Hameed Khan a*, Sharjeel Abbas b, Attaullah Khan Naizi c, Madiha Iqbal c ABSTRACT OBJECTIVE: To evaluate myocardial
More informationDemonstration of Uneven. the infusion on myocardial temperature was insufficient
Demonstration of Uneven in Patients with Coronary Lesions Rolf Ekroth, M.D., HAkan erggren, M.D., Goran Sudow, M.D., Josef Wojciechowski, M.D., o F. Zackrisson, M.D., and Goran William-Olsson, M.D. ASTRACT
More informationCold crystalloid versus warm blood cardioplegia in patients undergoing aortic valve replacement
Original Article Cold crystalloid versus warm blood cardioplegia in patients undergoing aortic valve replacement Paolo Nardi 1, Sara R. Vacirca 1, Marco Russo 1, Dionisio F. Colella 2, Carlo Bassano 1,
More informationSupplementary material 1. Definitions of study endpoints (extracted from the Endpoint Validation Committee Charter) 1.
Rationale, design, and baseline characteristics of the SIGNIFY trial: a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical
More informationmyocardial protection. during Prolonged Aortic Cross-Clamping wih Cold Blood Potassium Cardioplegia
Mvocardial Protection wih Cold Blood Potassium Cardioplegia during Prolonged Aortic Cross-Clamping Frank P. Catinella, M.D., Joseph N. Cunningham, Jr., M.D., Peter X. Adams, M.D., Steven L. Snively, M.D.,
More informationThe strategy of sequential use of antegrade and. Can Retrograde Cardioplegia Alone Provide Adequate Protection for Cardiac Valve Surgery?
Can Retrograde Cardioplegia Alone Provide Adequate Protection for Cardiac Valve Surgery?* Nirupama G. Talwalkar, MD, FCCP; Gerald M. Lawrie, MD, FCCP; Nan Earle, BS; and Michael E. DeBakey, MD, FCCP Background:
More informationin Patients Having Aortic Valve Replacement John T. Santinga, M.D., Marvin M. Kirsh, M.D., Jairus D. Flora, Jr., Ph.D., and James F. Brymer, M.D.
Factors Relating to Late Sudden Death in Patients Having Aortic Valve Replacement John T. Santinga, M.D., Marvin M. Kirsh, M.D., Jairus D. Flora, Jr., Ph.D., and James F. Brymer, M.D. ABSTRACT The preoperative
More informationMirsad Kacila*, Katrin Schäfer, Esad Subašić, Nermir Granov, Edin Omerbašić, Faida Kučukalić, Ermina Selimović-Mujčić
& Influence of Two Different Types of Cardioplegia on Hemodilution During and After Cardiopulmonary Bypass, Postoperative Chest-Drainage Bleeding and Consumption of Donor Blood Products Mirsad Kacila*,
More informationRandomized comparison of single versus double mammary coronary artery bypass grafting: 5 year outcomes of the Arterial Revascularization Trial
Randomized comparison of single versus double mammary coronary artery bypass grafting: 5 year outcomes of the Arterial Revascularization Trial Embargoed until 10:45 a.m. CT, Monday, Nov. 14, 2016 David
More informationCardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition
Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition Table of Contents Volume 1 Chapter 1: Cardiovascular Anatomy and Physiology Basic Cardiac
More informationImpact of TOE on delivery of antegrade cardioplegia
Impact of TOE on delivery of antegrade cardioplegia David Canty Senior Lecturer + Director of Simulation Department of Surgery, University of Melbourne Cardiac Anaesthetist Royal Melbourne Hospital + Monash
More informationJournal of the American College of Cardiology Vol. 33, No. 6, by the American College of Cardiology ISSN /99/$20.
Journal of the American College of Cardiology Vol. 33, No. 6, 1999 1999 by the American College of Cardiology ISSN 0735-1097/99/$20.00 Published by Elsevier Science Inc. PII S0735-1097(99)00061-3 for Prediction
More informationValue of serum magnesium estimation in diagnosing myocardial infarction and predicting dysrhythmias after coronary artery bypass grafting
Thorax 1983;38:946-95 Value of serum magnesium estimation in diagnosing myocardial infarction and predicting dysrhythmias after coronary artery bypass grafting RICHARD W BUNTON From the Department of Cardiothoracic
More informationPerioperative myocardial cell injury: the role of troponins
British Journal of Anaesthesia 1997; 78: 386 390 Perioperative myocardial cell injury: the role of troponins H. METZLER, M. GRIES, P. REHAK, TH. LANG, S. FRUHWALD AND W. TOLLER Summary Early recognition
More informationEACTS Adult Cardiac Database
EACTS Adult Cardiac Database Quality Improvement Programme List of changes to Version 2.0, 13 th Dec 2018, compared to version 1.0, 1 st May 2014. INTRODUCTORY NOTES This document s purpose is to list
More informationHigh Risk PCI for Heart Failure
High Risk PCI for Heart Failure Ray Matthews MD Professor of Clinical Medicine Chief, Division of Cardiovascular Medicine University of Southern California Los Angeles, California Disclosures Abiomed Research
More informationContinuing improvement in surgical technique, cardiopulmonary
Stroke After Coronary Artery Bypass Grafting Robert A. Baker, PhD, Lisa J. Hallsworth, BPsych(Hons), and John L. Knight, FRACS Cardiac Surgical Research Group, Cardiac and Thoracic Surgery, Flinders Medical
More informationHeart transplantation is the gold standard treatment for
Organ Care System for Heart Procurement and Strategies to Reduce Primary Graft Failure After Heart Transplant Masaki Tsukashita, MD, PhD, and Yoshifumi Naka, MD, PhD Primary graft failure is a rare, but
More informationTo ECMO Or Not To ECMO Challenges of venous arterial ECMO. Dr Emily Granger St Vincent s Hospital Darlinghurst NSW
To ECMO Or Not To ECMO Challenges of venous arterial ECMO Dr Emily Granger St Vincent s Hospital Darlinghurst NSW The Start: 1972 St Vincent s Hospital The Turning Point ECMO program restarted in 2004
More informationCARDIOVASCULAR N-terminal pro-b-type natriuretic peptide levels and early outcome after cardiac surgery: a prospective cohort study
CARDIOVASCULAR N-terminal pro-b-type natriuretic peptide levels and early outcome after cardiac surgery: a prospective cohort study B. H. Cuthbertson 1 *, B. L. Croal 2, D. Rae 1, P. H. Gibson 3, J. D.
More informationThe Effect of Acute Coronary Artery Occlusion during Cardioplegic Arrest
The Effect of Acute Coronary Artery Occlusion during Cardioplegic Arrest and Reperfusion on Myocardial Preservation John H. Rousou, M.D., Richard M. Engelman, M.D., William A. Dobbs, Ph.D., and Mooideen
More informationUniversity of Florida Department of Surgery. CardioThoracic Surgery VA Learning Objectives
University of Florida Department of Surgery CardioThoracic Surgery VA Learning Objectives This service performs coronary revascularization, valve replacement and lung cancer resections. There are 2 faculty
More informationTSDA ACGME Milestones
TSDA ACGME Milestones Short MW and Edwards JA. Assessing resident milestones using a CASPE March 2012 Short MW and Edwards JA. Assessing resident milestones using a CASPE March 2012 Short
More informationClinical Investigation and Reports. Effectiveness of Coronary Artery Bypass Grafting With or Without Cardiopulmonary Bypass in Overweight Patients
Clinical Investigation and Reports Effectiveness of Coronary Artery Bypass Grafting With or Without Cardiopulmonary Bypass in Overweight Patients Raimondo Ascione, MD; Barnaby C. Reeves, DPhil; Karen Rees,
More informationCounterpulsation. John N. Nanas, MD, PhD. Professor and Head, 3 rd Cardiology Dept, University of Athens, Athens, Greece
John N. Nanas, MD, PhD Professor and Head, 3 rd Cardiology Dept, University of Athens, Athens, Greece History of counterpulsation 1952 Augmentation of CBF Adrian and Arthur Kantrowitz, Surgery 1952;14:678-87
More informationIntra-operative Echocardiography: When to Go Back on Pump
Intra-operative Echocardiography: When to Go Back on Pump GREGORIO G. ROGELIO, MD., F.P.C.C. OUTLINE A. Indications for Intraoperative Echocardiography B. Role of Intraoperative Echocardiography C. Criteria
More informationPerioperative Management of TAPVC
Perioperative Management of TAPVC Professor Andrew Wolf Rush University Medical Center,Chicago USA Bristol Royal Children s Hospital UK I have no financial disclosures relevant to this presentation TAPVC
More informationIntra-operative Effects of Cardiac Surgery Influence on Post-operative care. Richard A Perryman
Intra-operative Effects of Cardiac Surgery Influence on Post-operative care Richard A Perryman Intra-operative Effects of Cardiac Surgery Cardiopulmonary Bypass Hypothermia Cannulation events Myocardial
More informationThinking outside of the box Perfusion management and myocardial protection strategy for a patient with sickle cell disease
Thinking outside of the box Perfusion management and myocardial protection strategy for a patient with sickle cell disease Shane Buel MS, RRT 1 Nicole Michaud MS CCP PBMT 1 Rashid Ahmad MD 2 1 Vanderbilt
More informationCase scenario V AV ECMO. Dr Pranay Oza
Case scenario V AV ECMO Dr Pranay Oza Case Summary 53 y/m, k/c/o MVP with myxomatous mitral valve with severe Mitral regurgitation underwent Mitral valve replacement with mini thoracotomy Pump time nearly
More informationIntraoperative application of Cytosorb in cardiac surgery
Intraoperative application of Cytosorb in cardiac surgery Dr. Carolyn Weber Heart Center of the University of Cologne Dept. of Cardiothoracic Surgery Cologne, Germany SIRS & Cardiopulmonary Bypass (CPB)
More informationTroponin-I (ctni) and troponin-t (ctnt) are wellestablished
Comparison of and After Pediatric Cardiovascular Operation Franz F. Immer, MD, Franco P. Stocker, MD, Andrea M. Seiler, MD, Jean-Pierre Pfammatter, MD, Gerhardt Printzen, MD, and Thierry P. Carrel, MD
More informationAcute coronary syndrome. Dr LM Murray Chemical Pathology Block SA
Acute coronary syndrome Dr LM Murray Chemical Pathology Block SA13-2014 Acute myocardial infarction (MI) MI is still the leading cause of death in many countries It is characterized by severe chest pain,
More informationWarm blood cardioplegia has been proposed as a
Intermittent Antegrade Warm Versus Cold Blood : A Prospective, Randomized Study L. Conrad Pelletier, MD, Michel Carrier, MD, Yves Leclerc, MD, Raymond Cartier, MD, Eva Wesolowska, MD, and B. Charles Solymoss,
More informationStatistical analysis plan
Statistical analysis plan Prepared and approved for the BIOMArCS 2 glucose trial by Prof. Dr. Eric Boersma Dr. Victor Umans Dr. Jan Hein Cornel Maarten de Mulder Statistical analysis plan - BIOMArCS 2
More informationIschemic Heart Disease Interventional Treatment
Ischemic Heart Disease Interventional Treatment Cardiac Catheterization Laboratory Procedures (N = 11,61) is a regional and national referral center for percutaneous coronary intervention (PCI). A total
More informationRationale for Prophylactic Support During Percutaneous Coronary Intervention
Rationale for Prophylactic Support During Percutaneous Coronary Intervention Navin K. Kapur, MD, FACC, FSCAI Assistant Director, Interventional Cardiology Director, Interventional Research Laboratories
More informationThe prevalence of permanent cardiac pacing after. Permanent Cardiac Pacing After a Cardiac Operation: Predicting the Use of Permanent Pacemakers
Permanent Cardiac Pacing After a Cardiac Operation: Predicting the Use of Permanent Pacemakers Richard S. Gordon, BSc, Joan Ivanov, MSc, Gideon Cohen, MD, and Anthony L. Ralph-Edwards, MD Division of Cardiovascular
More informationAlfa Ferry FRCS Cardiac Surgeon OPERATIVE MANAGEMENT IN CORONARY ARTERY DISEASE
Alfa Ferry FRCS Cardiac Surgeon OPERATIVE MANAGEMENT IN CORONARY ARTERY DISEASE Management in CHD Medical (medikamentosa) Intervensi 1. Percutaneous ( PTCA & stenting ) 2. Surgical ( CABG, CABG & mitral
More informationCoronary Artery Bypass Graft: Monitoring Patients and Detecting Complications
Coronary Artery Bypass Graft: Monitoring Patients and Detecting Complications Madhav Swaminathan, MD, FASE Professor of Anesthesiology Division of Cardiothoracic Anesthesia & Critical Care Duke University
More informationDiagnostic, Technical and Medical
Diagnostic, Technical and Medical Approaches to Reduce CABG Related Stroke Pieter Kappetein, Michael Mack, M.D. Dept Thoracic Surgery, Rotterdam, The Netherlands Baylor Healthcare System Dallas, TX Background
More informationSUPPLEMENTAL MATERIAL
SUPPLEMENTAL MATERIAL Table S1: Number and percentage of patients by age category Distribution of age Age
More informationIn the name of GOD. Animal models of cardiovascular diseases: myocardial infarction & hypertension
In the name of GOD Animal models of cardiovascular diseases: myocardial infarction & hypertension 44 Presentation outline: Cardiovascular diseases Acute myocardial infarction Animal models for myocardial
More informationSection 6 Intra Aortic Balloon Pump
Section 6 Intra Aortic Balloon Pump The Intra Aortic Balloon Pump (IABP) The balloon is synthetic and is made for single use only. It is threaded into the aorta, usually via a femoral approach. The balloon
More informationThe Preservation of a Traumatically Amputated Limb Utilizing Crystalloid Cardioplegia Solution-A Case Report
PROCEEDINGS The Preservation of a Traumatically Amputated Limb Utilizing Crystalloid Cardioplegia Solution-A Case Report William G. Maurer, Louie C. Wilson, William R. Higgs, John E. Stone, Thomas J. Gibson,
More informationChairman and O. Wayne Isom Professor Department of Cardiothoracic Surgery Weill Cornell Medicine
Leonard N. Girardi, M.D. Chairman and O. Wayne Isom Professor Department of Cardiothoracic Surgery Weill Cornell Medicine New York, New York Houston Aortic Symposium Houston, Texas February 23, 2017 weill.cornell.edu
More informationMyocardial Protection During Antegrade Versus Retrograde Cardioplegia
Myocardial Protection During Antegrade Versus Retrograde Cardioplegia Päivi K. Kaukoranta, MD, Martti V. K. Lepojärvi, MD, Kai T. Kiviluoma, MD, PhD, Kari V. Ylitalo, MD, and Keijo J. Peuhkurinen, MD,
More informationMWLCEMS SYSTEM Continuing Education Packet Management of the Acute MI Patient
MWLCEMS SYSTEM Continuing Education Packet Management of the Acute MI Patient In this CE we will discuss the patient presenting with an acute ST-Elevation Myocardial Infarction (STEMI) Definition: Myocardial
More informationCoronary artery bypass grafting (CABG) without an
Coronary Artery Bypass Grafting on the Beating Heart Evaluated With Integrated Backscatter Kenichi Imasaka, MD, Shigeki Morita, MD, Ichiro Nagano, MD, Munetaka Masuda, MD, Ryuji Tominaga, MD, and Hisataka
More informationIschemic Heart Disease Interventional Treatment
Ischemic Heart Disease Interventional Treatment Cardiac Catheterization Laboratory Procedures (N = 89) is a regional and national referral center for percutaneous coronary intervention (PCI). A total of
More informationEDUCATIONAL COMMENTARY CARDIAC FUNCTION: BIOCHEMICAL MARKERS UPDATE
EDUCATIONAL COMMENTARY CARDIAC FUNCTION: BIOCHEMICAL MARKERS UPDATE Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE
More informationApplication of Multivariate Analysis to the Enzvme Patterns in the Serum of Patients Undergoiig Coronary Artery Operation
Application of Multivariate Analysis to the Enzvme Patterns in the Serum of Patients Undergoiig Coronary Artery Operation L. Dieter Voegele, M.D., Alan J. Gross, Ph.D., William H. Prioleau, Jr., M.D.,
More informationNeurologic Events After Coronary Bypass Grafting: Further Observations With Warm Cardioplegia
Neurologic Events After Coronary Bypass Grafting: Further Observations With Warm Cardioplegia Joseph M. Craver, MD, Bradley L. Bufkin, MD, William S. Weintraub, MD, and Robert A. Guyton, MD Division of
More informationSupplementary Table 1. Details of the components of the primary composite endpoint
Supplementary Table 1. Details of the components of the primary composite endpoint 1. Death The cause of death will be defined by the underlying cause, not the immediate mode of death. Death will be classified
More informationClinical Study Decrease of Total Antioxidative Capacity in Developed Low Cardiac Output Syndrome
Oxidative Medicine and Cellular Longevity Volume 202, Article ID 35630, 4 pages doi:0.55/202/35630 Clinical Study Decrease of Total Antioxidative Capacity in Developed Low Cardiac Output Syndrome Alper
More informationEmergency Intraoperative Echocardiography
Emergency Intraoperative Echocardiography Justiaan Swanevelder Department of Anaesthesia, Glenfield Hospital University Hospitals of Leicester NHS Trust, UK Carl Gustav Jung (1875-1961) Your vision will
More informationTMR Clinical Application and Surgical Technique. Physician Training
TMR Clinical Application and Surgical Technique Physician Training Clinical Application Surgical procedure Performed as in-patient General anesthetic Image courtesy of Keith Allen, MD, St. Vincent Hospital,
More informationA Change in Myocardial Preservation Strategies using the Quest Medical MPS 2 System
A Change in Myocardial Preservation Strategies using the Quest Medical MPS 2 System Jim MacDonald, CPC,CCP Clinical Perfusion Services, London Health Sciences Centre London, Ontario, Canada Why the Change
More informationThe Coronary Baroreflex in Humans
The Journal of The American Society of Extra-Corporeal Technology The Coronary Baroreflex in Humans K. Kincaid, BSc(Hon);* M. Ward, HNC;* U. Nair, FRCS;* R. Hainsworth, Prof; M. Drinkhill, PhD *Yorkshire
More informationThe Case for Multivessel Revascularization in Shock
The Case for Multivessel Revascularization in Shock Emmanouil S. Brilakis, MD, PhD Minneapolis Heart Institute 9.37 9.49 am Disclosures Consulting/speaker honoraria: Abbott Vascular, American Heart Association
More informationJ. Schwitter, MD, FESC Section of Cardiology
J. Schwitter, MD, FESC Section of Cardiology CMR Center of the CHUV University Hospital Lausanne - CHUV Switzerland Centre de RM Cardiaque J. Schwitter, MD, FESC Section of Cardiology CMR Center of the
More informationIHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT JANUARY 24, 2012
IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT201203 JANUARY 24, 2012 The IHCP to reimburse implantable cardioverter defibrillators separately from outpatient implantation Effective March 1, 2012, the
More informationIntraaortic Balloon Counterpulsation- Supportive Data for a Role in Cardiogenic Shock ( Be Still My Friend )
Intraaortic Balloon Counterpulsation- Supportive Data for a Role in Cardiogenic Shock ( Be Still My Friend ) Stephen G. Ellis, MD Section Head, Interventional Cardiology Professor of Medicine Cleveland
More informationAtrial fibrillation (AF) is the most frequently encountered postoperative. Fibrillation in patients subjected to coronary artery bypass grafting CSP
Wu et al Cardiopulmonary Support and Physiology Fibrillation in patients subjected to coronary artery bypass grafting Zhong-Kai Wu, MD, PhD a Tiina Iivainen, MD, PhD b Erkki Pehkonen, MD, PhD a Jari Laurikka,
More informationThe Efficacy of Low Prime Volume Completely Closed Cardiopulmonary Bypass in Coronary Artery Revascularization
Original Article The Efficacy of Low Prime Volume Completely Closed Cardiopulmonary Bypass in Coronary Artery Revascularization Hideaki Takai, MD, Kiyoyuki Eishi, MD, Shiro Yamachika, MD, Shiro Hazama,
More informationIs Reperfusion Injury from Multiple Aortic Cross-Clamping a Current Myth of Cardiac Surgery?
ORIGINAL ARTICLES Is Reperfusion Injury from Multiple Aortic Cross-Clamping a Current Myth of Cardiac Surgery? David M. Lolley, M.D., Jefferson F. Ray, 111, M.D., William 0. Myers, M.D., Richard D. Sautter,
More informationIschemic Heart Disease
Ischemic Heart Disease Dr Rodney Itaki Lecturer Division of Pathology University of Papua New Guinea School of Medicine & Health Sciences Division of Pathology General Consideration Results from partial
More information